Boost in spine biologics demand drives global spine surgery market: 4 observations

Written by Megan Wood | April 24, 2018 | Print  |

The global spinal surgery devices market will hit $13 billion by 2022, based on a Wise Guy Reports analysis, according to Medgadget.

Here are four observations.

1. Key market players include DePuy Synthes, Globus Medical, Medtronic, NuVasive, Stryker and Zimmer Biomet.

2. An increasing number of spinal disorder cases are driving the market.

3. The demand for spine biologics represents a growing market trend.

4. Complications related to spine devices and surgeries will present a barrier to market growth.

More articles on devices:
NuVasive, OrthoPediatrics & more: 4 device company launches, releases
Global thoracolumbar spine devices market to grow at 3.8% CAGR through 2022: 4 observations
How will proposed Trump, China tariffs affect medtech and healthcare? 5 key thoughts

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months